Cost of Illness Analysis of Insulin and Insulin-Metformin Combination Usage towards Diabetes Mellitus Type 2 Patients at Hospital in Bandung

Journal Title: Indonesian Journal of Clinical Pharmacy - Year 2018, Vol 7, Issue 1

Abstract

Diabetes mellitus (DM) type 2 is a progressive disease that impact on the patients incurred costs during the illness. This study was conducted on May to June at one of hospital in Bandung. This study aimed to obtain cost of illness calculation of insulin monotherapy and insulin-metformin combination in patients with type 2 diabetes using Cost of Illness analysis (COI). This study used cross-sectional method with retrospective data collection on outpatients with 6 months therapy period in 2013. The cost of the measured components are direct medical costs (the cost of doctor visits, medicine costs, costs of complications and the cost of laboratories test) and human capital (HC) such as indirect non-medical costs (lost revenue per day). The results show the value of COI in the six months treatment of insulin and insulin-metformin combination sequentially 661,063.59 IDR and 443,165.28 IDR. This study shows that the use of combination therapy of insulin-metformin has lower cost of illness compared with insulin monotherapy and statistically (student t-test) showed significant differences p=0.004 (p<0.05).

Authors and Affiliations

Mally G. Sholih, Ahmad Muhtadi, Siti Saidah

Keywords

Related Articles

Effect of Chemotherapy Bleomycin, Vincristin, Mitomycin and Carboplatin by Tumor Mass and Infiltration Parametrial for Cervical Cancer Patients: Case Study in Sanglah General Hospital, Denpasar

BOM-cisplatin regimen for chemotherapy for cervical cancer patients has not resulted high efficacy, hence a replacement of cisplatin with carboplatin is proposed. BOM-carboplatin chemotherapy is at present a treatment fo...

Formulation of the Model Fluconazole Eye Drop and Its Comparison with the Available Fluconazole Eye Drops

The aim of the study was to formulate the model formulation of fluconazole eye drop and then compare it with the available eye drops. The corneal permeation studies were conducted using freshly excised sheep cornea, moun...

Ocular Insert: Dosage Form for Sustain Opthalmic Drug Delivery

Except for skin, the eye is the most easily accessible site for topical administration of a medication. Traditional topical ophthalmic formulations (eye drops and ointments) have poor bioavailability because of rapid pre...

Quality of Life Evaluation of Respondents with Hypertension Aged 40–75 Years Using SF-36 Instruments in Kalasan District, Sleman, Yogyakarta Province

Hypertension is a condition of an increase of systolic blood pressure over 140 mmHg and diastolic blood pressure over 90 mmHg. Poor health status indicates poor quality of life. There are many factors that may affect the...

Enhancing Pharmacist’s Role and Tuberculosis Patient Outcomes Through Training-Education-Monitoring-Adherence-Networking (TEMAN) Pharmacist Model Intervention

Training-Education-Monitoring-Adherence-Networking (TEMAN) Pharmacist model provides opportunities for trained pharmacist to intervene through education of tuberculosis (TB) patient, therapy monitoring, assessment of pat...

Download PDF file
  • EP ID EP370211
  • DOI 10.15416/ijcp.2018.7.1.10
  • Views 82
  • Downloads 0

How To Cite

Mally G. Sholih, Ahmad Muhtadi, Siti Saidah (2018). Cost of Illness Analysis of Insulin and Insulin-Metformin Combination Usage towards Diabetes Mellitus Type 2 Patients at Hospital in Bandung. Indonesian Journal of Clinical Pharmacy, 7(1), 10-18. https://europub.co.uk./articles/-A-370211